Neeraj Masand

452 total citations
32 papers, 265 citations indexed

About

Neeraj Masand is a scholar working on Computational Theory and Mathematics, Molecular Biology and Hepatology. According to data from OpenAlex, Neeraj Masand has authored 32 papers receiving a total of 265 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Computational Theory and Mathematics, 12 papers in Molecular Biology and 8 papers in Hepatology. Recurrent topics in Neeraj Masand's work include Computational Drug Discovery Methods (17 papers), Hepatitis C virus research (8 papers) and Synthesis and biological activity (4 papers). Neeraj Masand is often cited by papers focused on Computational Drug Discovery Methods (17 papers), Hepatitis C virus research (8 papers) and Synthesis and biological activity (4 papers). Neeraj Masand collaborates with scholars based in India, United States and Malaysia. Neeraj Masand's co-authors include Vaishali M. Patil, Saroj Verma, Vijay H. Masand, Satya P. Gupta, Savita Gupta, Subir Samanta, Anand Gaurav, K. Balasubramanian, Vannajan Sanghiran Lee and Priyanka Garg and has published in prestigious journals such as SHILAP Revista de lepidopterología, Life Sciences and Current Medicinal Chemistry.

In The Last Decade

Neeraj Masand

31 papers receiving 251 citations

Peers

Countries citing papers authored by Neeraj Masand

Since Specialization

Citations

This map shows the geographic impact of Neeraj Masand's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neeraj Masand with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neeraj Masand more than expected).

Fields of papers citing papers by Neeraj Masand

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Neeraj Masand. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neeraj Masand. The network helps show where Neeraj Masand may publish in the future.

Co-authorship network of co-authors of Neeraj Masand

This figure shows the co-authorship network connecting the top 25 collaborators of Neeraj Masand. A scholar is included among the top collaborators of Neeraj Masand based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Neeraj Masand. Neeraj Masand is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Molecular Targets and Therapeutic Interventions Against Neurodegenerative Diseases 2025 ·Vaishali M. Patil, Dileep Kumar, Neeraj Masand	1
2	Recent advances and structure-activity relationship studies of DPP-4 inhibitors as anti-diabetic agents 2024 ·Bioorganic Chemistry ·(unknown), Vaishali M. Patil, Saroj Verma, Neeraj Masand	11
3	Nanotechnology-based Drug Delivery of Topical Antifungal Agents 2023 ·Pharmaceutical Nanotechnology ·(unknown), Vaishali M. Patil, Sarvesh Paliwal, Neeraj Masand	2
4	Preclinical to Clinical Profile of Curcuma longa as Antidiabetic Therapeutics 2023 ·Current Topics in Medicinal Chemistry ·Shikha Kaushik, Neeraj Masand, Malliga R. Iyer, Vaishali M. Patil	5
5	Artificial intelligence and machine-learning approaches in structure and ligand-based discovery of drugs affecting central nervous system 2022 ·Molecular Diversity ·(unknown), Anand Gaurav, Neeraj Masand, Vannajan Sanghiran Lee, Vaishali M. Patil	18
6	Non-cancer to anti-cancer: investigation of human ether-a-go-go-related gene potassium channel inhibitors as potential therapeutics 2021 ·Journal of the Egyptian National Cancer Institute ·Vaishali M. Patil, Anand Gaurav, Priyanka Garg, Neeraj Masand	7
7	Prospective mode of action of Ivermectin: SARS-CoV-2 2021 ·SHILAP Revista de lepidopterología ·Vaishali M. Patil, Saroj Verma, Neeraj Masand	5
8	Chromones: Privileged scaffold in anticancer drug discovery 2021 ·Chemical Biology & Drug Design ·Vaishali M. Patil, Neeraj Masand, Saroj Verma, Vijay H. Masand	63
9	A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trials 2020 ·Life Sciences ·Vaishali M. Patil, (unknown), Neeraj Masand	34
10	Understanding Molecular Process and Chemotherapeutics for the Management of Breast Cancer 2020 ·Current Chemical Biology ·Kumar Abhishek, Neeraj Masand, Vaishali M. Patil	1
11	Natural Product Databases and Tools for Anti-cancer Drug Discovery 2020 ·Mini-Reviews in Medicinal Chemistry ·Vaishali M. Patil, Neeraj Masand	6
12	N-Substituted Aryl Sulphonamides as Potential Anti-Alzheimer’s Agents: Design, Synthesis and Biological Evaluation 2018 ·Current Computer - Aided Drug Design ·Neeraj Masand, Satya P. Gupta, (unknown)	7
13	HCV Inhibitors: Role of Compounds from Botanical Sources 2016 ·Current Topics in Medicinal Chemistry ·Vaishali M. Patil, Neeraj Masand, Satya P. Gupta	7
14	GENIUS In Silico Screening Technology for HCV Drug Discovery 2016 ·Current Drug Discovery Technologies ·Vaishali M. Patil, Neeraj Masand, Satya P. Gupta	2
15	Synthesis, In Vitro and In Silico NS5B Polymerase Inhibitory Activity of Benzimidazole Derivatives 2012 ·Medicinal Chemistry ·Vaishali M. Patil, (unknown), (unknown), Satya P. Gupta, (unknown), Neeraj Masand, Neerja Kaushik‐Basu	7
16	3D-QSAR and Docking Studies on a Series of Benzothiadiazine Derivatives as Genotype 1 HCV Polymerase Inhibitors 2012 ·Medicinal Chemistry ·Vaishali M. Patil, Satya P. Gupta, (unknown), Neeraj Masand	2
17	k nearest neighbor-molecular field analysis on human HCV NS5B polymerase inhibitors: 2,5-disubstituted imidazo[4,5-c]pyridines 2012 ·Medicinal Chemistry Research ·Savita Gupta, (unknown), Neeraj Masand, Vaishali M. Patil	2
18	Current Perspective of HCV NS5B Inhibitors: A Review 2011 ·Current Medicinal Chemistry ·Vaishali M. Patil, Savita Gupta, Subir Samanta, Neeraj Masand	22
19	3D QSAR kNN-MFA studies on thiouracil derivatives as hepatitis C virus inhibitors 2010 ·Medicinal Chemistry Research ·Vaishali M. Patil, Savita Gupta, (unknown), Neeraj Masand	7
20	Synthesis and anticonvulsant activities of small n-substituted 2, 5-dimethyl pyrrole and bipyrrole 2009 ·Vaishali M. Patil, (unknown), Neeraj Masand, Jainendra Jain	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact